Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-20

Clinical Trial Update: Study Evaluating the Efficacy and Safety of Artesunate [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating the efficacy and safety of artesunate for cytomegalovirus infection, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)

Snippet

Sponsor: Amivas Inc. | Conditions: CMV Infection | Phase 2 | Status: RECRUITING